Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection
- 1 April 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 789 (1) , 9-22
- https://doi.org/10.1016/s0006-8993(97)01495-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseasesCell and tissue research, 1996
- 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the ratExperimental Brain Research, 1996
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Therapeutic Potentials for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Based upon Pharmacological Activities in the CNSReviews in the Neurosciences, 1996
- Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeysJournal of Comparative Neurology, 1995
- Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsJournal of Comparative Neurology, 1995
- GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivoBrain Research, 1995
- Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivoBrain Research Bulletin, 1995
- Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeuroscience Letters, 1994
- Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkeyNeuroscience, 1986